Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02716 |
| Species: | Homo sapiens |
| Position : | chr1:42614062-42616745 |
| Year: | 2022 |
| Title: | A ζ±-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal Cancer. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | acute myeloid leukemia |
| PMID: | 34954189 |
| MONDO: | MONDO:0018874 |
| Tissue: | bone marrow |
| Tissue Ontology ID: | UBERON:0002371 |
| Cell Source: | Primary AML blasts |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq; RNA-seq |
| Low Throughput Method: | Luciferase Reporter Assay; CRISPR Knockout; CRISPRi; CRISPRa; ChIP-RT-qPCR; RT-RT-qPCR; CRISPR-Cas9 |
| Target gene : | GUCA2B |
| TF name : | NA |
| Regulatory State : | Repressed |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_02711 | chr1:42614062-42616745 | colon | malignant cell | colorectal cancer |